Breadcrumb

What's New at the RI-MUHC ?

Can inhaled corticosteroids alleviate early symptoms of COVID-19?

Results from the CONTAIN study conducted at the RI-MUHC reveal that ciclesonide is no better than placebo

Regular screening for tuberculosis in Inuit communities is cost-effective

A new study from RI-MUHC researchers published in CMAJ recommends regular screening to help reduce outbreaks

RI-MUHC team detects impact of HIV antiretroviral therapy on the anti-tuberculosis immune response

Alveolar macrophages, cells important for protection from tuberculosis infection, are adversely impacted by...

The 2021 RI-MUHC Annual Report is online!

An invitation from Dr. Rhian Touyz

Discovery of mechanics of drug targets for COVID-19

Scientists unravel inner workings of cell receptors involved in inflammatory diseases

RI-MUHC researchers tackle COVID-19 vaccine hesitancy in adults and in children

Videos from projects led by Drs. Inés Colmegna and Moshe Ben-Shoshan are now available

RI-MUHC leads study of antiviral use in children hospitalized for influenza

Findings show that influenza antivirals are underutilized in Canadian pediatric hospitals, despite national clinical...

RI-MUHC scientist part of McGill team delivering World Alzheimer Report 2021

Alzheimer’s Disease International webinar launches report on World Alzheimer Day, September 21

RI-MUHC researcher Sasha Bernatsky leads nationwide COVID-19 vaccination study

New study will assess impact of the vaccines on Canadians with immune-mediated inflammatory disease

Learn more about the RI-MUHC